Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-011707

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael S Hearne
Officer — Chief Financial Officer
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 15, 2019A39$14.04A835D
Common StockF2holding———12,946,038IBy LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$16.52Feb 15, 2019A39A—Feb 15, 2029Common Stock3939D

Explanation of responses